An observational study in Myocarditis and Pericarditis, sponsored by Emergent BioSolutions. Completed at 1 site in United States. Open to participants aged 17 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-18.
Sponsored by Emergent BioSolutions · Observational
The purpose of this registry is to study the natural history of vaccination-related myocarditis and pericarditis and to assess possible risk factors for these conditions.
Primary Objective:
Other Pre-defined Objective:
All participants will have received previous vaccination with ACAM2000 but will not receive any vaccination as part of the registry. All participants enrolled in the registry will be followed for 2 up to 5 years (depending on whether there are persisting signs and symptoms of myopericarditis).
174 studies on the registry are indexed under Myocarditis; 75 are open to participants now.
This study's enrollment of 24 is below the median of 208 across 120 observational studies indexed under Myocarditis.
Browse Myocarditis studies →Emergent BioSolutions is the lead sponsor of 47 studies on the registry; 7 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 7 (64%) have results posted.
Counted across the registry records on this site, refreshed daily.
Eligible participants will have received previous vaccination with ACAM2000® but will not receive any vaccination as part of the registry.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants with potential myopericarditis cases referred to the Registry
The number of confirmed, probable, suspected, and subclinical cases of myopericarditis, categorized by time since vaccination
Time frame: 2 years after enrollment or after the last symptoms or positive findings
The natural history of myopericarditis in terms of time to resolution or change in status of myopericarditis and the pattern of changes in status of myopericarditis
Time frame: 2 years after enrollment or after the last symptoms or positive findings
The record gives a start of Apr 2011, a primary completion of Feb 2019 and a completion of Feb 2019. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.